PDSB
PDS Biotechnology Corp
-0.12 (-12.11%)0.87USD27.1M成交股數48.8M市值–本益比(近四季)–股價營收比–營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q2 | 24Q1 | 23Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | – | – | – | – | – | – | – | – | – | – | – | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 3.3M | 3.5M | – | 4.6M | 4.2M | 5.8M | – | 6.8M | 4.5M | – | 6.7M | – |
| 銷售管理費用 | 3.2M | 3.1M | – | 3.6M | 3.4M | 3.3M | – | 3.4M | 4.2M | – | 3.4M | – |
| 營業利益 | −6.5M-15% | −6.5M-28% | – | −8.1M-20% | −7.6M-12% | −9.1M | – | −10.2M | −8.7M | – | −10.1M | – |
| 營業利益率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稅後淨利 | −9.8M+3% | −7.3M-13% | −7.6M-5% | −9.0M-16% | −9.4M+13% | −8.5M | −8.0M-25% | −10.7M-2% | −8.3M | – | −10.6M | −10.9M |
| 淨利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 稀釋 EPS | -0.18-14% | -0.13-38% | – | -0.19-34% | -0.21-9% | -0.21 | – | -0.29 | -0.23 | – | -0.30 | – |
| 稀釋股數 | 55.7M | 55.5M | – | 46.9M | 45.9M | 40.5M | – | 36.8M | 36.7M | – | 34.8M | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q2 | 24Q1 | 23Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 5.6M | 21.7M | 26.7M | 26.2M | 31.9M | 40.0M | 41.7M | 49.8M | 57.7M | – | 66.6M | 56.6M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 8.8M | 24.7M | 30.5M | 34.7M | 40.5M | 47.0M | 45.4M | 52.5M | 60.5M | – | 69.0M | 59.4M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 12.4M | 20.8M | 21.2M | 25.3M | 24.5M | 24.7M | 26.4M | 30.4M | 29.6M | – | 31.8M | 33.3M |
| 股東權益 | −3.6M | 3.9M | 9.3M | 9.5M | 16.0M | 22.4M | 19.0M | 22.0M | 30.9M | – | 37.2M | 26.1M |
| 負債比 | 140.6% | 84.2% | 69.7% | 72.8% | 60.6% | 52.4% | 58.1% | 58.1% | 48.9% | – | 46.1% | 56.0% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q2 | 24Q1 | 23Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −4.4M-52% | – | – | – | −9.0M | – | – | – | – | −9.9M | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | −34.5M | –% | -0.74 | −27.8M |
| FY2024 | – | – | −37.6M | –% | -1.03 | −35.1M |
| FY2023 | – | – | −42.9M | –% | -1.39 | −33.6M |
| FY2022 | – | – | −40.9M | –% | -1.43 | – |
| FY2021 | – | – | −16.9M | –% | -0.66 | – |
| FY2020 | – | – | −14.8M | –% | -0.89 | – |
| FY2019 | – | – | −7.0M | –% | -1.44 | – |
| FY2018 | – | – | −3.8M | –% | 1.15 | −1.6M |